software package sas release 9.2 (SAS institute)
SAS institute is a verified supplier 
90
Structured Review
SAS institute
software package sas release 9.2
Software Package Sas Release 9.2, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+package+sas+release+9%2E2/sas+version+9+4/10__1097_slash_rli__0000000000001224-86-7-8
Average 90 stars, based on 1 article reviews
Software Package Sas Release 9.2, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+package+sas+release+9%2E2/sas+version+9+4/10__1097_slash_rli__0000000000001224-86-7-8
Average 90 stars, based on 1 article reviews
software package sas release 9.2 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Exploratory evaluation of pharmacodynamics, pharmacokinetics and safety of rivaroxaban in children and adolescents: an EINSTEIN-Jr phase I study Article Snippet: Statistical evaluation was performed using the software Article Title: Bioequivalence Evaluation Between Acarbose and Metformin Fixed-Dose Combination and Corresponding Individual Components in Healthy Chinese Male and Female Subjects. Article Snippet: All the statistical evaluations were performed using the software Article Title: Pharmacokinetics and Safety of the Selective Progesterone Receptor Modulator Vilaprisan in Chinese Healthy Postmenopausal Women Article Snippet: The statistical evaluation was conducted using the software Article Title: Efficacy and safety in patients with haemophilia A switching to octocog alfa (BAY 81-8973): Final results of the global real-world study, TAURUS. Article Snippet: Statistical evaluation was performed by using the software Article Title: Pharmacokinetics and Safety of the Novel Selective Progesterone Receptor Modulator Vilaprisan in Participants With Renal Impairment Article Snippet: The statistical evaluation was performed by using the software Article Title: First evaluation of the safety, pharmacokinetics, and pharmacodynamics of BAY 2433334, a small molecule targeting coagulation factor XIa Article Snippet: The statistical evaluation was performed using the software Article Title: Pharmacokinetic interaction of riociguat and antiretroviral combination regimens in HIV-1-infected adults Article Snippet: Statistical analyses were performed using the software Article Title: Clinical Safety of Gadoxetate Disodium Article Snippet: Statistical analyses were performed using the software |